Edition:
United States

Atrion Corp (ATRI.OQ)

ATRI.OQ on NASDAQ Stock Exchange Global Select Market

596.75USD
26 Jun 2017
Change (% chg)

-- (--)
Prev Close
$596.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,334
52-wk High
$600.00
52-wk Low
$394.00

ATRI.OQ

Chart for ATRI.OQ

About

Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company's medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety. It has... (more)
No analyst recommendations are available for ATRI.OQ.

Overall

Beta: 0.94
Market Cap(Mil.): $1,070.86
Shares Outstanding(Mil.): 1.84
Dividend: 1.05
Yield (%): 0.72

Financials

  ATRI.OQ Industry Sector
P/E (TTM): 35.38 34.18 19.01
EPS (TTM): 16.48 -- --
ROI: 18.16 13.01 -5.03
ROE: 19.34 15.52 -4.28

BRIEF-Atrion Q1 earnings per share $5.36

* Q1 revenue $38.5 million versus $36.2 million Source text for Eikon: Further company coverage:

May 10 2017

BRIEF-Atrion on Feb. 28, Co entered into credit agreement with Wells Fargo Bank, National Association as lender

* Atrion - on february 28, 2017, co entered into credit agreement with wells fargo bank, national association, as lender

Mar 03 2017

BRIEF-Atrion reports Q4 earnings per share $3.00

* Q4 revenue $33.3 million versus $32.4 million Source text for Eikon: Further company coverage:

Feb 23 2017

More From Around the Web

Earnings vs. Estimates